melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery
home
Our Services
High Throughput In Vivo Pharmacology:
Our Technology
 

theraTRACE

Melior Pharmaceuticals

 

  

              

 

             

 

                 

melior melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling

Melior Discovery press

 
   

Melior Pharmaceuticals Announces Postive Phase 2A Results in Type 2 Diabetes Study
Press Release
June 13, 2016

Download PDF »

melior

 

Melior Discovery Announces Spinout of Melior Pharmaceuticals II, LLC
Press Release
May 10, 2016

Download PDF »

melior

 

Melior Pharmaceuticals Achieves Partnership Milestone with Bukwang Pharmaceutical Co.
Press Release
March 15, 2016

Download PDF »

melior

 

Melior Discovery Receives Patent Approval from U.S. Patent and Trademark Office for New Parkinson's Disease Drug Candidate
Press Release
June 10, 2015

Download PDF »

melior

 

Melior Pharmaceuticals Initiates Phase 2 Study with MLR-1023 for
Type 2 Diabetes

Press Release
March 3, 2015

Download PDF »

melior


Melior Discovery Awarded SBIR Grant for Studying MLR-1023
Mechanism of Action

Press Release
December 11, 2014

Download PDF »

melior

 

Melior Pharmaceuticals Receives First Performance Milestone Payment
from Bukwang Pharmaceutical

Press Release
October 7, 2014

Download PDF »

melior


Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co.
Press Release
December 4, 2013

Download PDF »

melior

Melior Discovery Strengthens Scientific Leadership Team with Addition of Dr. Gregory Gatto and Biolucidation Assets
Press Release
July 9, 2013
Download PDF »

melior

Melior Discovery Announces Two Publications Describing New Therapeutic Opportunity in Diabetes
Press Release
April 17, 2012
Download PDF »

melior

Melior Pharmaceuticals Announces New Scientific Advisory Board Member Dr. John Amatruda, an Expert in the Field of Diabetes and Drug Development to Join Board
Press Release
November 8, 2011
Download PDF »

melior

Melior Discovery is Awarded Grant from Michael J. Fox Foundation
Press Release
August 16, 2011
Download PDF »

melior

Melior Discovery Strengthens Scientific Leadership Team with Addition of Dr. John Gruner
Press Release
September 28, 2010
Download PDF »

melior

Melior receives notice of allowance for method of use patent for repositioned drug candidate MLR-1023.
Press Release
June 8, 2010
Download PDF »

melior

Melior announces collaboration with Rett Syndrome Research Trust.
Press Release
March 30, 2010
Download PDF»

melior

Melior Announces IND Approval for Novel Diabetes Drug MLR1023
Press Release
March 16, 2009
Download PDF »

melior

Melior Enters Research Collaboration with AstraZeneca
Press Release
August 19, 2008
Download PDF »

melior

Melior Signs Option Agreement with Pfizer
Press Release
June 24, 2008
Download PDF »

melior

Repositioning Idle Drugs via Systematic Serendipity
Website Article
January 1, 2008
Download PDF »

melior

Recycling Existing Drugs
Website Article
January 1, 2008
Download PDF »

melior

Melior Discovery Enters New Pharmaceutical Collaboration with Johnson & Johnson
Press Release
August 2, 2007
Download PDF »

melior

Christopher Lipinski, PhD named in top ten most influential people in pharma;
Worldpharmaceuticals frontiers 2007 Edition pharma40

Website Article
April 9, 2007
Download PDF »

melior

Melior Enters Research Collaboration with Pfizer
Press Release
April 9, 2007
Download PDF »

Back to top of page